Provided by Tiger Trade Technology Pte. Ltd.

Savara Inc

5.59
+0.10001.82%
Post-market: 5.58-0.0100-0.18%19:46 EDT
Volume:3.04M
Turnover:16.95M
Market Cap:1.14B
PE:-9.67
High:5.64
Open:5.54
Low:5.50
Close:5.49
52wk High:7.01
52wk Low:2.98
Shares:204.66M
Float Shares:198.20M
Volume Ratio:1.85
T/O Rate:1.53%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5782
EPS(LYR):-0.5344
ROE:-105.48%
ROA:-50.15%
PB:7.96
PE(LYR):-10.46

Loading ...

Company Profile

Company Name:
Savara Inc
Exchange:
NASDAQ
Establishment Date:
2007
Employees:
70
Office Location:
The Tannery,Suite 200,19 W. College Avenue,West College Avenue,Yardley,Pennsylvania,United States
Zip Code:
19067
Phone:
- -
Fax:
- -
Introduction:
Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. The company's lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase 3 development stage for the treatment of autoimmune pulmonary alveolar proteinosis. Savara Inc. is headquartered in Austin, Texas.

Directors

Name
Position
Robert Neville
Chairman and Chief Executive Officer
David A. Ramsay
Director
Joseph S. McCracken
Director
Matthew Pauls
Director
Nevan Elam
Director
Richard J. Hawkins
Director
Yuri Pikover
Director

Shareholders

Name
Position
Robert Neville
Chairman and Chief Executive Officer
Taneli Jouhikainen
President and Chief Operating Officer
David Lowrance
Chief Financial Officer